Palatin Technologies
PTN
#9895
Rank
S$48.39 M
Marketcap
S$28.43
Share price
6.95%
Change (1 day)
2,140.27%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -S$6.57 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$8.84 Million. In 2024 the company made an earning of -S$34.1 Million, an increase over its 2023 earnings that were of -S$41.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.57 Million-80.74%
2024 -S$34.1 Million-16.9%
2023 -S$41.03 Million5.99%
2022 -S$38.71 Million-13.7%
2021 -S$44.86 Million33.25%
2020 -S$33.66 Million-172.11%
2019 S$46.67 M2352.33%
2018 S$1.9 M-94.13%
2017 S$32.43 M-154.92%
2016 -S$59.06 Million3.67%
2015 -S$56.97 Million878%
2014 -S$5.83 Million-72.64%
2013 -S$21.29 Million-33.11%
2012 -S$31.83 Million77.71%
2011 -S$17.91 Million
2003 -S$30.33 Million29.93%
2002 -S$23.35 Million36.18%
2001 -S$17.14 Million
1999 -S$14.23 Million6.04%
1998 -S$13.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.00 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.56 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$0.73 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.2 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$84.53 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.15 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$63.97 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$37.32 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$70.31 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA